2j4w: Difference between revisions

New page: left|200px<br /> <applet load="2j4w" size="450" color="white" frame="true" align="right" spinBox="true" caption="2j4w, resolution 2.50Å" /> '''STRUCTURE OF A PLAS...
 
No edit summary
Line 1: Line 1:
[[Image:2j4w.gif|left|200px]]<br />
[[Image:2j4w.gif|left|200px]]<br /><applet load="2j4w" size="350" color="white" frame="true" align="right" spinBox="true"  
<applet load="2j4w" size="450" color="white" frame="true" align="right" spinBox="true"  
caption="2j4w, resolution 2.50&Aring;" />
caption="2j4w, resolution 2.50&Aring;" />
'''STRUCTURE OF A PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX'''<br />
'''STRUCTURE OF A PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX'''<br />


==Overview==
==Overview==
Apical membrane antigen 1 (AMA1) has an important, but as yet, uncharacterised, role in host cell invasion by the malaria parasite, Plasmodium. The protein, which is quite conserved between Plasmodium, species, comprises an ectoplasmic region, a single transmembrane segment, and a small cytoplasmic domain. The ectoplasmic region, which can induce, protective immunity in animal models of human malaria, is a leading, vaccine candidate that has entered clinical trials. The monoclonal, antibody F8.12.19, raised against the recombinant ectoplasmic region of, AMA1 from Plasmodium vivax, cross-reacts with homologues from Plasmodium, knowlesi, Plasmodium cynomolgi, Plasmodium berghei and Plasmodium, falciparum, as shown by immunofluorescence assays on mature schizonts. The, binding of F8.12.19 to recombinant AMA1 from both P. vivax and P., falciparum was measured by surface plasmon resonance, revealing an, apparent affinity constant that is about 100-fold weaker for the, cross-reacting antigen when compared to the cognate antigen. Crystal, structure analysis of Fab F8.12.19 complexed to AMA1 from P. vivax and P., falciparum shows that the monoclonal antibody recognises a discontinuous, epitope located on domain III of the ectoplasmic region, the major, component being a loop containing a cystine knot. The structures provide a, basis for understanding the cross-reactivity. Antibody contacts are made, mainly to main-chain and invariant side-chain atoms of AMA1; contact, antigen residues that differ in sequence are located at the periphery of, the antigen-binding site and can be accommodated at the interface between, the two components of the complex. The implications for AMA1 vaccine, development are discussed.
Apical membrane antigen 1 (AMA1) has an important, but as yet uncharacterised, role in host cell invasion by the malaria parasite, Plasmodium. The protein, which is quite conserved between Plasmodium species, comprises an ectoplasmic region, a single transmembrane segment and a small cytoplasmic domain. The ectoplasmic region, which can induce protective immunity in animal models of human malaria, is a leading vaccine candidate that has entered clinical trials. The monoclonal antibody F8.12.19, raised against the recombinant ectoplasmic region of AMA1 from Plasmodium vivax, cross-reacts with homologues from Plasmodium knowlesi, Plasmodium cynomolgi, Plasmodium berghei and Plasmodium falciparum, as shown by immunofluorescence assays on mature schizonts. The binding of F8.12.19 to recombinant AMA1 from both P. vivax and P. falciparum was measured by surface plasmon resonance, revealing an apparent affinity constant that is about 100-fold weaker for the cross-reacting antigen when compared to the cognate antigen. Crystal structure analysis of Fab F8.12.19 complexed to AMA1 from P. vivax and P. falciparum shows that the monoclonal antibody recognises a discontinuous epitope located on domain III of the ectoplasmic region, the major component being a loop containing a cystine knot. The structures provide a basis for understanding the cross-reactivity. Antibody contacts are made mainly to main-chain and invariant side-chain atoms of AMA1; contact antigen residues that differ in sequence are located at the periphery of the antigen-binding site and can be accommodated at the interface between the two components of the complex. The implications for AMA1 vaccine development are discussed.


==About this Structure==
==About this Structure==
2J4W is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] and [http://en.wikipedia.org/wiki/Plasmodium_vivax Plasmodium vivax]. Full crystallographic information is available from [http://ispc.weizmann.ac.il/oca-bin/ocashort?id=2J4W OCA].  
2J4W is a [http://en.wikipedia.org/wiki/Protein_complex Protein complex] structure of sequences from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus] and [http://en.wikipedia.org/wiki/Plasmodium_vivax Plasmodium vivax]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2J4W OCA].  


==Reference==
==Reference==
Line 15: Line 14:
[[Category: Plasmodium vivax]]
[[Category: Plasmodium vivax]]
[[Category: Protein complex]]
[[Category: Protein complex]]
[[Category: Bentley, G.A.]]
[[Category: Bentley, G A.]]
[[Category: Faure, G.]]
[[Category: Faure, G.]]
[[Category: Igonet, S.]]
[[Category: Igonet, S.]]
[[Category: Kocken, C.H.M.]]
[[Category: Kocken, C H.M.]]
[[Category: Normand, B.Vulliez-Le.]]
[[Category: Normand, B Vulliez-Le.]]
[[Category: Riottot, M.M.]]
[[Category: Riottot, M M.]]
[[Category: Thomas, A.W.]]
[[Category: Thomas, A W.]]
[[Category: antibody cross-reactivity]]
[[Category: antibody cross-reactivity]]
[[Category: apical membrane antigen 1]]
[[Category: apical membrane antigen 1]]
Line 33: Line 32:
[[Category: transmembrane]]
[[Category: transmembrane]]


''Page seeded by [http://ispc.weizmann.ac.il/oca OCA ] on Sun Nov 18 09:51:16 2007''
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Thu Feb 21 17:59:11 2008''

Proteopedia Page Contributors and Editors (what is this?)Proteopedia Page Contributors and Editors (what is this?)

OCA